Immediate Impact
60 standout
Citing Papers
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Jacques Cretin being referenced
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial
2018
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jacques Cretin | 167 | 55 | 62 | 85 | 83 | 9 | 324 | |
| J. Provençal | 143 | 74 | 84 | 74 | 166 | 10 | 355 | |
| L. Casanova | 191 | 27 | 14 | 45 | 30 | 11 | 305 | |
| Zora Baretta | 149 | 20 | 25 | 72 | 12 | 14 | 325 | |
| Dany Gholam | 117 | 45 | 10 | 33 | 25 | 16 | 282 | |
| Richard J. Ugoretz | 74 | 36 | 7 | 49 | 17 | 9 | 293 | |
| Cornelius Maihöfer | 87 | 52 | 8 | 65 | 8 | 6 | 277 | |
| Yi Zhang | 212 | 60 | 24 | 85 | 4 | 13 | 290 | |
| Tsugio Eto | 182 | 139 | 5 | 157 | 14 | 13 | 354 | |
| H. Auvray | 136 | 141 | 7 | 61 | 9 | 11 | 342 | |
| Keira Watts | 36 | 49 | 6 | 169 | 10 | 7 | 339 |
All Works
Loading papers...